Benedict R. Halbroth
Roosevelt Drive
Oxford, ENG, United Kingdom
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Phase I/IIa study to assess the safety, immunogenicity and efficacy of ChAdOx1-MVA vectored vaccines expressing a novel liver-stage malaria dual antigen LS2 by sporozoite challenge in malaria-naïve adults.
Journal: Wellcome open research
Published: March 19, 2026
Preclinical Development and Assessment of Viral Vectors Expressing a Fusion Antigen of Plasmodium falciparum LSA1 and LSAP2 for Efficacy against Liver-Stage Malaria.
Journal: Infection and immunity
Published: July 26, 2019
Development of a Molecular Adjuvant to Enhance Antigen-Specific CD8+ T Cell Responses.
Journal: Scientific reports
Published: June 18, 2018
Prime and target immunization protects against liver-stage malaria in mice.
Journal: Science translational medicine
Published: September 08, 2017
Identification of Immunodominant Responses to the Plasmodium falciparum Antigens PfUIS3, PfLSA1 and PfLSAP2 in Multiple Strains of Mice.
Journal: PloS one
Published: September 28, 2015
Recent developments in malaria vaccinology.
Journal: Advances in parasitology
Published: April 26, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026